Inflammatory bowel diseases (IBD) are a chronic gastrointestinal disease with a significant burden of illness.12 In addition to significant economic and health costs, treatments for IBD are variable, and it is of increasing concern that many patients continue to receive sub-optimal care.34 Associative pathologies, such as CD and UC, can also have variable courses of disease progression. This heterogeneity makes it difficult to implement generally effective strategies, and consequently contributes to considerable variation in IBD care.5 However, standardized processes for care are essential to improve quality of care.6 In 2011, the American Gastroenterological Association (AGA) developed "An adult inflammatory bowel disease physician performance measures set" that comprised 10 specific measures. Eight of these measures were subsequently included in the Centers for Medicare and Medicaid Physician Quality Reporting System in 2012.7 As the incidence and prevalence of IBD has increased rapidly in Asia, quality of care is emerging as an important aspect of IBD care in Asia.8910 The current quality of care status for IBD has, however, not been systematically investigated in Asia. In this study, we performed a questionnaire-based survey to evaluate the delivery of performance measures for IBD care in the current Asian practice.

The questionnaire-based survey was designed by the organizing committee of the Asian Organization of Crohn's and Colitis (AOCC) and reviewed by staff officer members of the organization. The questionnaire comprised 11 questions, adopted from "An adult inflammatory bowel disease physician performance measure set" developed by the AGA. Details of the questionnaire are provided in the Appendix. A multinational web-based survey was conducted between March 2014 and May 2014 by the IBD study group of the Korean Association for the Study of Intestinal Diseases (KASID). Physicians involved with IBD treatment at major institutions in Asian countries were invited by e-mail to participate in the survey. The delivery of each performance measure was assessed based on a five–point Likert scale: always (responder performed the measure in 90%–100% of patients), usually (70%–90% of patients), sometimes (30%–70% of patients), rarely (10%–30% of patients) and never (0%–10% of patients), and a descriptive analysis of responses was conducted. The respondent was regarded to deliver a performance measure well if it was performed in more than 70% of patients. Categorical variables were analyzed by the χ² or Fisher's exact test. P-values <0.05 were considered significant and based on two-sided tests.

To the best of our knowledge, this study is the first to assess the delivery of performance measures for IBD treatment in Asian countries. The study population was gastroenterologists with significant expertise in IBD treatment in Asian countries.

We found considerable variation in the delivery of performance measures among Asian countries. Measures with a consistently high rank in delivery among all countries included testing for latent TB before the initiation of anti-TNF therapy, and the documentation of IBD. Currently, there is limited data about the delivery of performance measures in Western countries. In a recent study from a tertiary care center in the USA,11 compliance of testing for latent TB was 67%, ranked fifth among 8 measures for outpatient care, and compliance of documentation of IBD was 70%, and ranked fourth. A recent European study demonstrated a marked increase in TB screening before initiating anti-TNF therapy from 30% in 2003 to 97% in 2010. A similar adherence with these measures in Asian countries was not unexpected in this study as many of the countries included in the survey (China, Korea, India, the Philippines, Malaysia, and Indonesia) are TB endemic areas, and TB screening is an elementary component in the management of IBD.12 Lower ranked performance measures among Asian countries, including prophylaxis of VTEs, and pneumococcal and influenza vaccination were comparable to a similarly lower compliance in Western contries.11131415

Recent Western survey data suggests that the rates of pharmacologic prophylaxis of VTEs in hospitalized patients with IBD is less than 40%.1316 Despite reasonable awareness of the increased risk of thrombosis in hospitalized IBD patients, many physicians do not follow clinical practice guidelines, and prophylaxis for VTEs are underutilized.16 In this study, only 24% of respondents from Asian countries performed well considering prophylaxis for VTEs. A recent systematic review explained the reason for lower delivery of this measure in Asian countries as a lower demonstrated risk of VTE in Asian general surgery patients, even in patients at high risk.17 However, there is limited data about risk of VTEs in Asian IBD patients,18 and there is currently a need for consensus among Asian countries about prophylaxis for VTEs based on clinical data from Asian IBD patients.

The awareness of quality measures has been regarded as an important factor in performance,11121319202122 and in the present study, there was a positive association between awareness and delivery of performance measures among Asian countries. However, performance measures such as IBD documentation and TB screening before anti-TNF therapy were not affected significantly, as respondents implemented these measures without awareness. This result indicates that the dissemination, transfer of knowledge, and change of attitude towards documentation of IBD, and TB screening before anti-TNF therapy may have already occurred among Asian doctors.15 Nevertheless, further education regarding the impact of performance measures in IBD patients is needed among Asian countries.

Reasons for non-performance varied among countries especially for lower ranked performance measures. The Asian countries included in our study differ markedly in their demography, country income classification, and economic resources allocated for healthcare.23 These factors could influence the differences observed in the delivery of performance measures. For example, respondents from other Asian countries indicated that cost was the main barrier for bone loss assessment in patients on high doses of corticosteroids. Dual-energy x-ray absorptiometry (DXA) is the gold standard for bone loss assessment. However, it is relatively expensive and not widely available in most developing countries. In areas without reimbursement, the cost of DXA is often prohibitively high for the average wage earner. On the other hand, Asian countries like Japan, Singapore, and Korea have better developed systems easily available for DXA.24

The majority of respondents indicated a lack of time or that they did not consider vaccination to be important in IBD care. Studies have shown that knowledge about available vaccinations that could be recommend for IBD patients is poor.202225 A lack in the availability of incidence data may also influence unawareness and knowledge deficiency among physicians in Asia. For example, limited data are available regarding the burden and epidemiology of pneumococcal disease in adults, particularly in Asia.26 There are also, to the best of our knowledge, no English-language articles published on the incidence of pneumococcal disease in adults in China, India, Indonesia, Japan, the Philippines, and Korea. Five countries (Indonesia, Malaysia, Singapore, Thailand, and Vietnam) have guidelines for influenza vaccination but only two are consistent with global guidelines,23 and the rate of vaccination in Asian countries continues to remain low. Educational programs on vaccinations, tailored towards gastroenterologists who care for patients with IBD, are therefore still needed.

The present study, however, also has several limitations that must be considered. The survey investigated the delivery of performance measures in each country by relying on the physician's memory recall, and therefore, this does not accurately reflect the performance of each country. While several studies have examined the magnitude of parental recall or patient's recall bias for immunization status,27 few studies have looked at the validity of recall in physicians. The self-reporting of influenza and pneumococcal vaccines was highly sensitive and moderately specific in elderly adults when compared with medical records. Even if we might assume that physicians would have better recall than patients would, further study based on medical records is still needed.

Another aspect for consideration is the differing characteristics of the study respondents between countries. Japanese respondents collectively had more respondents with a significant number of years of experience with IBD care and the Chinese respondent sample had more women respondents. The delivery of a few performance measures indicated significant differences that were dependent on these characteristics. It is however difficult to ascertain whether these differences could be attributed to the characteristics of the respondents surveyed or a sampling bias, as the characteristics of the total population of physicians who treat IBD in each country is not known.

Respondents from Korea had a tendency to select "lack of time" as the reason for non-performance while respondents from Japan frequently selected "the status of patients". Culture is a consistently significant factor in predicting an individual's social question-and-answer behavior.28 Because the study questionnaire was composed of exclusive choice questions, other possible reasons for non-performance could be masked by answer selection based on cultural influences. In addition, the response rate of questions for reasons for non-performance was very low in performance measures with high adherence. Therefore, the validity of those values is also contestable.

In conclusion, a notable variation was found in the delivery of performance measures among Asian countries. To reach a consensus in physician performance measures reflecting differences in Asian IBD patients, we must understand and decrease this variation among Asian countries. Local data on disease burden, cost effectiveness, acceptability, coverage, and delivery strategies are needed to inform the development and implementation of performance measures. The AOCC needs to play an important role to ensure consistency in the level of care across different national settings.